Obtaining self-samples to diagnose curable sexually transmitted infections: a systematic review of patients' experiences by Paudyal, Priyamvada et al.
RESEARCH ARTICLE
Obtaining Self-Samples to Diagnose
Curable Sexually Transmitted Infections:
A Systematic Review of Patients’ Experiences
Priyamvada Paudyal1*, Carrie Llewellyn1, Jason Lau1, MohammadMahmud2,
Helen Smith1
1 Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, United
Kingdom, 2 North-West Thames London Deanery, London, United Kingdom
* p.paudyal@bsms.ac.uk
Abstract
Background
Routine screening is key to sexually transmitted infection (STI) prevention and control. Pre-
vious studies suggest that clinic-based screening programmes capture only a small propor-
tion of people with STIs. Self-sampling using non- or minimally invasive techniques may be
beneficial for those reluctant to actively engage with conventional sampling methods. We
systematically reviewed studies of patients’ experiences of obtaining self-samples to diag-
nose curable STIs.
Methods
We conducted an electronic search of MEDLINE, EMBASE, CINAHL, PsychINFO, BNI,
and Cochrane Database of Systematic Reviews to identify relevant articles published in En-
glish between January 1980 and March 2014. Studies were included if participants self-
sampled for the diagnosis of a curable STI and had specifically sought participants’ opinions
of their experience, acceptability, preferences, or willingness to self-sample.
Results
The initial search yielded 558 references. Of these, 45 studies met the inclusion criteria.
Thirty-six studies assessed patients’ acceptability and experiences of self-sampling. Pooled
results from these studies shows that self-sampling is a highly acceptable method with 85%
of patients reporting the method to be well received and acceptable. Twenty-eight studies
reported on ease of self-sampling; the majority of patients (88%) in these studies found self-
sampling an “easy” procedure. Self-sampling was favoured compared to clinician sampling,
and home sampling was preferred to clinic-based sampling. Females and older participants
were more accepting of self-sampling. Only a small minority of participants (13%) reported
pain during self-sampling. Participants were willing to undergo self-sampling and recom-
mend others. Privacy and safety were the most common concerns.
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Conclusion
Self-sampling for diagnostic testing is well accepted with the majority having a positive ex-
perience and willingness to use again. Standardization of self-sampling procedures and rig-
orous validation of outcome measurement will lead to better comparability across studies.
Future studies need to conduct rigorous economic evaluations of self-sampling to inform
policy development for the management of STI.
Introduction
Sexually transmitted infections (STIs) impose an enormous burden on sexual and reproductive
health worldwide. Over a million people acquire a STI every day and around 500 million new
cases of curable STIs (chlamydia, gonorrhoea, syphilis and trichomoniasis) occur each year [1].
Despite surveillance, monitoring and multiple interventions aimed at prevention, diagnosis
and treatment of STIs, these infections continue to place a significant burden on healthcare re-
sources. In the UK, approximately 510,000 new STI diagnoses (other than HIV) were made in
2011, with estimated treatment costs of £620 million [2].
Routine screening is an important component of STI prevention and control. However, it
has been recognised that an effective response to the global STI epidemic necessitates alterna-
tive strategies beyond the traditional approach of clinic-based sampling and conventional cul-
ture methods for screening [3] [4]. Earlier studies have reported that clinic based screening
programmes capture only a small proportion of people with STIs; mainly due to barriers such
as clinic inaccessibility, lack of privacy, embarrassment, discomfort, and the lack of time or fi-
nancial resources needed to attend appointments [5] [6]. With the advent of new technologies
in STI diagnosis, screening outside of the clinic environment is now more feasible than before.
Self-sampling using non-invasive or minimally invasive sampling techniques such as urine
samples, cervical-brush, vaginal swabs, and tampons have demonstrated an equivalent or supe-
rior detection of STIs compared to conventional sampling and detection methods [7]. These
techniques have been found to be particularly beneficial for those where access to medical care
is difficult [7] and for vulnerable individuals who are often reluctant to visit sexual health clin-
ics due to fear of embarrassing and painful intimate examinations. Self-sampling is also helpful
in screening for STIs where individuals affected may be completely asymptomatic, but if their
condition is left undetected and untreated it could potentially lead to serious complications
such as pelvic inflammatory disease (PID), infertility (as in the case of Chlamydia) or transmis-
sion to sexual partners [8]. Self-sampling is not only beneficial to the patient, but could be help-
ful in reducing healthcare costs by averting major complications of STIs [9] [10].
There has been a plethora of research on the diagnostic accuracy, sensitivity and specificity
of self-sampling methods in relation to conventional ‘gold standards’. Fewer studies have
looked at patients’ acceptance of these methods and preferences for self-sampling compared to
conventional methods. Patient’s preferences and perspectives are important in successful tai-
loring of STI screening and treatment services. Earlier reviews have mostly focused on accept-
ability of HPV self-sampling [11,12] and HIV self-testing [13]. One recently published
systematic review and meta-analysis compared the effectiveness and acceptability of home-
based self-sampling and clinic based specimen collection for STIs [14]. However, the review
only included a small number of studies and were confined to female participants. Our study
aims to systematically review the literature of patients’ experiences, acceptability and prefer-
ences for self-sampling to diagnose curable STIs. We believe that the findings of this review
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will be helpful in formulating strategies to facilitate earlier diagnosis of STIs, which are accept-
able to patients.
Materials and Methods
This systematic review was conducted and reported following the PRISMA (Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses) guidelines (http://www.prisma-
statement.org/).
Eligibility criteria
Studies were eligible if they (i) involved human participants who had undergone self-sampling for
the diagnosis of curable STI(s) (ii) reported on patients’ experiences, acceptance, preferences, or
willingness to undergo self-sampling (iii) included primary data; (iv) were published in English.
Studies using any means of self-obtained samples including vaginal/rectal/penile/vulval swabs,
cervical/vaginal lavage, cervical brush, tampons, urine, stools, throat gargle, or finger-prick blood
spot for diagnostic purposes were included. Studies that were excluded were those addressing self-
examination for cancer (such as breast/testicular examination), home-care, self-sampling for moni-
toring or management of pre-existing conditions (such as diabetes, blood pressure or anticoagula-
tion therapy), acceptability of vaccinations or any form of home treatment. It was felt that these
may reflect different views to self-sampling for diagnostic reasons. In addition, focus groups or
other studies where the procedures were merely described and not experienced were not included.
Information sources and Search
An electronic search was undertaken of the following databases to identify relevant articles
published between January 1980 and March 2014: MEDLINE(R), EMBASE, CINAHL, Psy-
chINFO, BNI, and Cochrane Database of Systematic Reviews. The bibliographies of included
studies were also searched for relevant articles. Grey literatures, including conference abstracts,
unpublished reports or other non-peer reviewed articles, were excluded from the search, as the
quality of the contents cannot be assured.
Search terms
Where advanced search engines were available, search terms for obtaining self-sample (self-
sampl, home-sampl, self-test, home-test, self-swab, home-swab, self-collect, home-
collect) were combined with search terms for patient opinion (Acceptab, prefer, experi-
ence, feasib). Where there were limited search options, the terms self-testing/sampling and
acceptability, or preference, or experience or feasibility were used.
Study selection, data extraction, and quality assessment
Two reviewers (PP and JL) independently carried out the search, screened the titles of the arti-
cles and removed any irrelevant and duplicate articles. Abstracts of the remaining articles were
assessed applying the inclusion criteria. Any disagreements in selections were discussed and re-
solved during consensus meetings involving a third investigator (CL or HS).
The following relevant information were extracted from the selected studies: study charac-
teristics (author, year of publication, country), disease, method of self-sampling, explanation of
self-sampling procedure, location of sampling, total number of participants involved in study,
total number of participants who provided opinion, response rate, method of ascertaining ac-
ceptability/experience (Table 1). The quality of reporting of individual studies was assessed by
two independent reviewers (all authors involved) with reference to a standardised checklist of
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quality items recommended by the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) Statement [15].
Results
A total of 558 references were initially identified from the computerized search but 410 were
excluded after screening the titles. Abstracts of the remaining 148 articles were retrieved for
further scrutiny, and after reviewing the abstracts, 45 studies described in 47 articles were
found to be eligible for inclusion (Table 1).
Overall, the majority of studies were conducted in Western countries; 24 studies were con-
ducted in North America (23 USA, 1 Canada), 13 in Europe (9 UK, 4 Netherlands), 2 in Asia
(1 Thailand, 1 India), 2 Oceania (Australia), 3 in Africa (2 in South Africa and 1 in Kenya), and
1 in South America (Brazil). The location of self-sampling varied between studies; 23 studies
were conducted in clinical settings, 10 in home/community settings, 3 across clinical and non-
clinical settings, 3 in government establishments (military forts, federal prisons or juvenile cor-
rectional facilities), 4 randomised into either home or clinic settings, and the locations for 2
were not reported. The age range of the populations in the included studies was 12–71 years
old. In most studies (n = 31), participants were given written instructions with or without illus-
trations or verbal explanations for their corresponding self-sampling procedures, 6 studies pro-
vided only verbal instructions, and the means of explanation was either not published or
unclear in the remaining eight studies.
There were large variations in response rate (defined as number of samples/ number of eligi-
ble participants) of the studies ranging from 18% to 100%. In general, studies utilizing postal
means of recruiting participants tended to have lower response rates compared to studies re-
cruiting in sexually transmitted disease (STD) clinics or other clinical environments. Informa-
tion on patient’s acceptability was commonly gathered via self-administered questionnaires
(SAQ) (n = 27) or interviewer-administered questionnaires (IAQ) (n = 7) or telephone inter-
viewer-administered questionnaires (TIAQ, n = 4) or face-to-face interview discussions (FID)
(n = 3) using only open-ended questions on a small number of selected participants. Two stud-
ies used a mixture of methods (SAQ & IAQ or SAQ & FID) and two studies did not report the
means of collecting information on acceptability. In most studies, these questionnaires or inter-
views were administered at the end of the study immediately after the participants performed
self-sampling with or without undergoing clinician sampling, a few sought participants’ opin-
ion both before and after self-sampling [16,17,18,19,20].
Outcome measures
There were considerable variations in how acceptability and experience were measured and re-
ported. Patients were commonly asked to comment on the ease of use, confidence, satisfaction
or other factors related to the method of self-sampling. The results are described below.
Acceptability and experience. Thirty-six studies recorded participants’ experience of or
opinion on self-sampling [3,5,16,17,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,
38,39,40,41,42,43,44,45,46,47,48,49,50] (S1 Table). Pooled results from these studies shows
that self-sampling is a highly acceptable method with 85% of patients reporting the method to
be well-received and acceptable (Table 2). Seventeen studies described participants’ desire to
self-sample rather than clinician sampling [16,17,24,25,27,29,30,31,32,35,36,38,40,43,45,46,47].
Seven of these compared participants’ preferences for self- versus clinician- administered sam-
pling after undergoing both procedures [25,29,32,35,36,45,46]. Five studies showed a strong
preference for self-sampling [25,29,36,45,46]. The participants’ preferences in the other two
studies were less conclusive showing only approximately half of the participants desiring self-
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Table 2. Patients’ experience of collecting self-sample*.
Patients’ Experience Study
Acceptability and experience (%)
Mean 85 SD (15)
Median 90
Range (29–100)
Bloomﬁeld 2003 [26]; Brown 2010 [37]; Chai 2010 [38]; Chernesky 2005 [29];
Dodge 2010 [17]; Freeman 2011 [46]; Gaydos 2006 [30]; Gaydos 2013[45]; Gotz
2005 [50]; Graseck 2010 [49]; Graseck 2010 [39]; Greenland 2011 [5]; Hoebe
2006 [31]; Holland-Hall [24]; Hsieh 2003 [48]; Huppert 2011 [19]; Jones 2007 [33];
Kimmitt 2010[40]; Lippman, 2007 [3]; Macmillan 2000 [22]; Markos 1994 [21];
Newman 2003 [27]; Papp 2007 [34]; Pimenta 2003 [28]; Reagan 2012 [41];
Richardson 2003 [16]; Roth 2013 [43]; Tanksale 2003 [42]; Van der Helm 2009
[35]; Van-de-Wijgert 2006[32]; Wayal 2009 [36]; Wiesenfeld 2001[47]
Ease of Sampling (%)
Mean 88 SD (11)
Median 93
Range (60–100)
Bloomﬁeld 2003 [26]; Chai 2010 [38]; Chernesky 2005 [29]; Fielder 2013 [52];
Freeman 2011 [46]; Gaydos 2006 [30]; Gotz 2005 [50]; Graseck 2010 [39];
Greenland 2011[5]; Hoebe 2006 [31]; Holland-Hall 2002 [24]; Hsieh 2003 [48];
Jones 2007 [33]; Kimmitt 2010 [40]; Kwan 2012 [53]; Lippman, 2007 [3]; Macmillan
2000 [22]; Mahilum Tapay 2007 [51]; Newman 2003 [27]; Papp 2007 [34]; Pimenta
2003 [28]; Reagan 2012 [41]; Roth 2013 [43]; Tanksale 2003 [42]; Van der Helm
2009 [35]; Van-de-Wijgert 2006 [32]; Wiesenfeld 2001 [47]
Pain and Discomfort (%)
Pain
Mean 13 SD (15)
Median
4 Range (0–42)
Hsieh 2003 [48]; Jones 2007 [33]; Roth 2013 [43]; Tanksale 2003 [42]; Van-de-
Wijgert 2006 [32]
Discomfort
Mean 13 SD (9)
Median 10
Range (0–32)
Berwald 2009 [55]; Bloomﬁeld 2002 [54]; Brown 2010 [37]; Fielder 2013 [52];
Hsieh 2003 [48]; Lippman, 2007 [3]; Macmillan 2000 [22]; Markos 1994 [21];
Newman 2003 [27]; Roth 2013 [43]; Van der Helm 2009 [35]; Wayal 2009 [36]
Conﬁdence in sampling and trust in Results (%)
Mean 84 SD (9)
Median 84
Range (64–95)
Dodge 2010 [17]; Gaydos 2013 [45]; Jones 2007 [33]; Lippman 2007 [3]; Markos
1999 [21]; Newman 2003 [27]; Stephenson 2000 [23]; Tanksale 2003 [42]
Concerns and Worries (%)~
Privacy
Mean 30 SD (19)
Median 26
Range (4–55)
Bloomﬁeld 2002 [54]; Bloomﬁeld 2003 [26]; Dodge 2010 [17]; Gaydos 2013 [45];
Graseck 2010 [49]; Gudka 2013 [44]; Stephenson 2000 [23]
Safety
Mean 17 SD (18)
Median 18
Range (2.0–43)
Bloomﬁeld 2002 [54]; Bloomﬁeld 2003 [26]; Chai 2010 [38]; Gaydos 2013 [45];
Gaydos 2006 [30]
Sampling preference (%)
Vaginal Swab
Mean 60 SD (21)
Median 55
Range (31–94)
Chernesky 2005 [29]; Fielder 2013 [52]; Gaydos 2006 [45]; Greenland 2011 [5];
Holland-Hall 2002 [24]; Hsieh 2003 [48]; Jones 2007 [33]; Kohli 2013 [59];
Macmillan 2000 [22]; Newman 2003 [27]; Tebb 2004 [58]
Urine
Mean 49 SD (26)
Median 45
Range (9.0–95)
Chernesky 2005 [29]; Fielder 2013 [52]; Gaydos 2006 [30]; Greenland 2011 [5];
Holland-Hall 2002 [24]; Hsieh 2003 [48]; Jones 2007 [33]; Kohli 2013 [59];
Macmillan 2000 [22]; Mahilum Tapay 2007 [51]; Newman 2003 [27]; Tebb2004
[58]
Clinic or home? (%)
Clinic
Mean 44 SD (23)
Median 42
Range (0.0–78)
Graseck 2010 [39]; Graseck 2010 [49]; Hsieh 2003 [48]; Jones 2007 [33]; Kimmitt
2010 [40]; Lippman, 2007 [3]; Reagan 2012 [41]; Tebb 2004 [58]; Van-de-Wijgert
2006 [32]
Home
Mean 65 SD (20)
Median
60 Range (24–100)
Graseck 2010 [39]; Graseck 2010 [49]; Hsieh 2003 [48]; Jones 2007 [33]; Kimmitt
2010 [40]; Lippman, 2007 [3]; Reagan 2012 [41]; Tebb 2004 [58]; Van-de-Wijgert
2006 [32]
(Continued)
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sampling [32,35]. A strong preference for clinician-sampling was justified by participants’ per-
ception of physicians as experts in sample taking [35]. An additional ten studies compared par-
ticipants’ preferences after performing self-sampling against hypothetical physician-sampling
and showed a strong preference for the former option [16,17,24,27,30,31,38,40,43,47]. Some
participants with no preferences were in favour for the most accurate test whichever it may be
[27]. One study compared self-sampling using oral-throat rinse with a hypothetical vignette of
a physician taken pharyngeal swab and found participants had mixed views with approximate-
ly half choosing each option [34]. In Gaydos et al.[30] participants’ who did not submit a self-
sample were also surveyed about their preference. They showed a stronger preference for phy-
sician examination compared to those who submitted a self-sample (25% vs. 13%).
Ease of sampling. Twenty-eight studies recorded participants’ views on the ease of use of
self-sampling methods[3,5,22,24,26,27,28,29,30,31,32,33,34,35,36,38,39,40,41,42,43,46,47,48,
50,51,52,53] (S1 Table). On average, 88% of patients reported that self-sampling was ‘very
easy’, ‘easy’ or ‘not difficult’ to perform (Table 2). Two studies [27,51], investigated the ease of
collection among other different self-sampling methods. In these studies, the majority of par-
ticipants found no difference in ease of collection between self-administered vaginal swabs and
urine sampling. Interestingly, in a study involving female military recruits in the US, Hsieh
et al [48] reported that white army recruits generally found self-administered vaginal swabs
easier compared to the black recruits.
Table 2. (Continued)
Patients’ Experience Study
Willingness to Use or Recommend of Self-Sampling (%)
Mean 86 SD (14)
Median 92
Range (50–100)
Chandeying 2004 [60]; Chernesky 2005 [29]; Dodge 2010 [17]; Fielder 2013 [52];
Gaydos 2006 [30]; Graseck 2010 [39]; Greenland 2011 [5]; Hoebe 2006 [31];
Holland-Hall 2002 [24]; Jones 2007 [33]; Kimmitt 2010 [40]; Kwan 2012 [53];
Macmillan 2000 [22]; Papp 2007 [34]; Pimenta 2003 [28]; Reagan 2012 [41]; Roth
2013 [43]; Van der Helm 2009 [35]; Van-de-Wijgert 2006 [32]; Wayal 2009 [36];
Wiesenfeld 2001 [47]
Reasons for Declining or Refusing to Self-Sample (%)
Lack of Time
Mean 25 SD (17)
Median 21
Range (7–62)
Fielder 2013 [52]; Graseck 2010 [39]; Greenland 2011 [5]; Gudka 2013[44];
Lippman 2007 [3]; Macmillan 2000 [22]; Richardson 2003 [16]; Serlin 2003 [25];
Tebb 2004 [58]
Discomfort/Dislike
Mean 25 SD (8)
Median 17
Range (2.0–60)
Fielder 2013 [52]; Macmillan 2000 [22]; Macmillan 2000 [22]; Newman 2003 [27];
Serlin 2002 [25]; Van der Helm 2009 [35]; Richardson 2003 [16]
Not being at risk
Mean 36 SD (8)
Median 40
Range (24–43)
Gudka 2013 [44]; Greenland 2011 [5]; Fielder 2013 [52]
Recently tested
Mean 36 SD (33)
Median 20
Range (12–93)
Graseck 2010 [39]; Graseck 2010 [49]; Graseck 2010 [5]; Gudka 2013 [44]
Menstruation
Mean 11 SD (13)
Median 2
Range (2.0–29)
Hoebe 2006 [31]; Kimmitt 2010 [40]; Macmillan 2000 [22]
*% not reported in some studies (see S1 Table for details)
doi:10.1371/journal.pone.0124310.t002
Patients' Experiences of Obtaining Self-Samples
PLOS ONE | DOI:10.1371/journal.pone.0124310 April 24, 2015 13 / 22
Pain and discomfort. The experience of pain or discomfort was reported in seventeen stud-
ies [3,21,22,25,27,32,33,35,36,37,42,43,46,48,52,54,55] (S1 Table). A small proportion of partici-
pants (13%) complained of these negative experiences (Table 2). Fielder et al [52] reported that
on average, women felt comfortable, relaxed and in control while obtaining the vaginal swab and
strongly disagreed that obtaining the sample was painful. When comparing various types of
sampling methods, Hsieh et al. [48] reported that women found self-administered vaginal swabs
significantly more painful than urine collection (2% vs.0.1%; p<0.05). A randomised controlled
trial (RCT) demonstrated that, despite using the same sampling method, participants felt more
pain self-sampling at home (17%) when compared to self-sampling in a clinic (12%) [33]. When
comparing the experiences of self-sampling (urine for men, vaginal swab for women) and clini-
cian-sampling (urethral swab for men and speculum examination and endocervical swabs in
women) in the same setting, one study indicated self-sampling was less painful or less uncom-
fortable than clinician-sampling [37]. A further study conducted in clinical setting reported that
the proportion of participants experiencing pain during clinician examination is much greater
(15%) than those self-sampling (3%) with tampons or vaginal swabs [32]. In contrast, another
study conducted in a clinical setting comparing the same sampling methods reported stronger
preferences towards clinician collected samples (60%, n = 45) as participants felt that self-admin-
istered swabs were uncomfortable and painful [42].
Confidence in sampling and trust in test results. Thirteen studies assessed participants’
level of confidence in obtaining self-samples or interpreting the results [3,17,19,20,21,23,25,27,
33,36,42,45,52] (S1 Table). Studies shows that majority of the participants (84%) expressed
confidence in doing the tests properly or believed they had taken the sample/ interpreted the
results correctly. Serlin et al.[25] found that despite self-sampling being the preferred method,
participants trusted the results of a physician pelvic examination the most, followed by urine
sampling, and self- vaginal swabbing the least. Studies by Huppert et al. [19,20] reported lower
trust in self-testing compared to clinician testing at baseline, with the trust increasing after test-
ing experience. After the discussion of the results, trust of self and clinician testing did not dif-
fer significantly [20]. Gaydos et al [45] also collected opinions from those who performed the
self-administered swab, with controls, who never performed self-sampling. Interestingly, it was
found that those who performed the test were more likely to think that the sampling procedure
was accurate compared to the controls (83% vs 63%).
Concerns and worries. Ten studies addressed, to a certain degree, participants’ concerns
and worries regarding self-sampling [17,23,26,28,30,38,39,44,45,54] (S1 Table). Privacy and
safety regarding self-collection of sample was the commonest issue of concern with 30% of pa-
tients being concerned about privacy and 17% regarding safety (Table 2). In a study from the
USA, consisting of mainly male participants, Bloomfield et al. [54] reported that 56% very wor-
ried about confidentiality, 54% about privacy, and 36% safety of screening using urine test kits
sent through the mail. The same group conducted further research [26] targeting both genders
which concluded that men (except men having sex with men (MSM)) are most likely to voice
concerns about self-sampling, followed by women, and MSM were the least likely to raise any
concerns. However, neither paper defined whether privacy meant ‘anonymity/confidentiality
of samples’ or ‘privacy during self-sampling’. Two studies recorded negative comments con-
cerning the delivery of the self-sampling method [17,28]. In Dodge et al. [17], MSM reported
that rectal swab self-sampling in community based venues lacked privacy, accuracy and sterili-
ty. Some participants (proportion not reported) in the study by Pimenta et al. [28] expressed
dissatisfaction about the handing out of containers and collecting specimens at the front desk
by the receptionist, instead of managing the specimen handling more discreetly.
Demographic characteristics. The characteristics of participants performing or willing to
perform self-sampling were reported in fewer studies. Only three studies looked at the
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acceptability of self-sampling by gender and found that females were more likely to accept, or be
willing to self-sample in the future [5,39,50]. Eight studies reported that older participants were
more willing to self-sample [3,19,27,28,41,48,49,56], three reported no difference by age
[29,37,57] and two reported older participants being less likely to choose self-sampling compared
to younger participants [5,32]. In three studies, level of educational attainment did not influence
acceptability of self-sampling [29,32,57]. One study, however, reported that low educational level
was significantly associated with increased willingness to test [5]. In some studies that looked at
differences between Caucasians and other ethnic minorities, it was noted that the former group
was more likely to accept, be comfortable with, and prefer self-sampling [39,48,54,56].
What type of self-sampling? Participants’ preferences towards self-sampling using urine
or self-administered vaginal or vulval swabs was assessed in 15 studies
[5,22,24,25,27,28,29,30,33,34,48,51,52,58,59] (S1 Table). A pooled result from these studies
shows that the preference for vaginal swab was slightly higher than urine (60% vs 49%). In a
study by Pimenta et al. [28], the majority of women commented they would not have partici-
pated in the study had there been a need to perform a vaginal swab. In a study involving mili-
tary recruits, Hsieh et al. [48] further explored whether women’s preferences would change
should the location of self-sampling vary (at home, in clinic, or in the field). It was found that
the majority of women’s sampling preference remained unchanged between locations.
Clinic or home? Participants’ opinions on the preferred location for self-sampling was as-
sessed in 11 studies [3,5,32,33,39,40,41,46,48,49,58] (S1 Table). Findings from these studies
suggest that participants prefer to self-sample at home (65%) than in clinic (44%) (Table 2). In
Regan et al. [41], men assigned to a home sampling kit were 60% more likely to complete
screening compared to men assigned to clinic screening. Common reasons given for such pref-
erences included ‘less embarrassment’, ‘convenience’, and ‘long waiting time’ in clinics [40]. In
one study, only a small proportion (12%) of the women found home testing an unpleasant con-
cept [5]. In another study based in South Africa [32], although the majority believed women
should be given the option to obtain the sample at home and bring to the clinic, most women
expressed a desire to self-sample in the clinic. Three recent RCTs yielded mixed conclusions
[3,33,39]. Two of these demonstrated women’s preferences were highly associated with their
randomisation groups [3,33]. The majority of participants preferred to self-sample in the set-
ting where they had the testing experience (i.e. home group preferred home self-sampling
while the clinic group preferred clinic self-sampling). In the third RCT study [39], it was re-
ported that while the majority in the home group expressed a preference for home self-sam-
pling, only half of those in the clinic group chose clinic self-sampling.
Willingness to use or recommend of self-sampling? Patients’ willingness to use self-
sampling again in the future was assessed in 21 studies [5,17,22,24,28,29,30,31,32,33,34,35,
36,39,40,41,43,47,52,53,60]. These studies found that majority of the patients (86%) were will-
ing to use the self-sampling methods in the future. Willingness to use self-sampling seemed to
apply to participants who were, prior to the study, naïve to using self-swabs [38]. Using self-
sampling methods, most participants would test more often [5,29,47]. One study conducted in
the USA reported that participants were willing to test between their regular pelvic exams [24].
An African study by van de Wijgert et al. [32] found that participants were more willing to
self-sample at home than in the clinic. Two additional clinic-based studies reported patients,
after being offered and undergoing self-sampling on that occasion, would be happy to undergo
self-sampling in the future [35,36,57]. In an American study by Gaydos et al. [30] 91% of the
‘questionnaire only’ submitters reported willingness to use further self-sampling method com-
pared to 86% test kit users. Five additional studies showed participants would recommend or
encourage family and friends to self-sample [17,22,28,41,43]. Current STI infection, female
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gender, younger age group, low education and having two or more sexual partners in the last 6
months were significantly associated with increased willingness to self-test in the future [5].
Reasons for Declining or Refusing to Self-Sample
Sixteen studies recorded the reasons given by potential participants who refused to self-sample
[3,5,16,17,22,25,27,31,35,36,39,40,44,49,52,58]. The most common reason was a lack of time
[3,5,16,22,25,44,49,52,58] or dislike/discomfort with the concept of vaginal swab/self-sampling
[16,22,25,27,35,36,52], followed by the perception of not being at risk, recently being tested
elsewhere and current menstruation. Other reasons included general lack of interest fear of in-
correct self-sampling technique, virginity, inability to understand the instructions/information,
lack of confidentiality, sanitary issues, the perception that they were not at risk for an STI or
not wanting to know if they had an STI.
Critical Appraisal of Study Quality
The study quality was assessed using criteria included in the STROBE statement [15] (S1
Table). All studies (45) had an abstract. Four studies (9%) did not clearly describe their recruit-
ment or participant selection methods [25,27,49,50], four (9%) did not socio-demographic de-
tails of the study population [21,34,40,52] and eight (18%) did not publish or clearly state their
means of providing self-sampling instructions (i.e. whether it was written, verbal, or video)
[17,25,27,28,37,56,58,59]. Two studies did not report their means of ascertaining participants’
opinion [3,59] and thirteen did not provide the source of funding [21,23,26,31,34,35,40,43,
46,53,54,55,59].
Discussion
To our knowledge, this is the first systematic review summarising patients’ experiences of ob-
taining self-samples to diagnose curable STIs. Reviewing 45 studies, it was found that patients
found self-sampling highly acceptable. The majority of participants who took part found it
very easy to collect the self-sample, which ranged from urine samples to oral gargle and were
willing to self-sample again in the future, and also to recommend self-sampling to family and
friends. Most did not have any unpleasant experiences performing the self-sampling proce-
dures, and preferred self-sampling to physician sampling. These results are consistent with pre-
vious review focussing on HPV self-sampling [11,12] and HIV self-testing [13].
Consistent with a previous review by Shih et al [61], we found that most patients preferred
to self-sample at home rather than in the clinic. Interestingly, it was found that people are
more compliant if the mode of testing reflects their preferences. In a recent study by Graseck
et al. [49], patients choosing to self-sample at home were twice as likely to actually complete
the test compared to those choosing the clinic option (where both self-sampling and non-self-
sampling means were offered). Therefore, one may regard this higher ‘compliance rate’ as a
secondary advantage of home-based self-screening over and above women’s choice. In recent
years self-sampling has emerged as an important tool in screening as well as being used as a
routine means of diagnostic sampling in a clinical setting. Professionals hold the belief that not
only does this reduce the workload of staff, but it also provides patients with greater autonomy,
privacy, and confidentiality [62]. However, this perspective is challenged by some patients.
Women in one of our included studies stated that should self-sampling be adopted instead of
their annual physician appointment, they would rather continue with pelvic examinations.
This view is further confirmed by a recent large survey (n = 2,887) across three American clinic
sites by Howard et al [63]. The authors reported, as an alternative to self-sampling, the majority
would prefer to wait to see a doctor, even if there is a hypothetical long wait and a substantial
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number would prefer to come back the next working day should the clinic turn patients away.
A recent UK study explored patients’ desire for clinician genital examination. Basta et al [64]
found that most asymptomatic patients (98% female, 91% male) presenting to the GUM clinic
were in favour of routine genital examination. The participants in this study had not knowingly
been in contact with any STI and there were no statistical difference in preferences between pa-
tients surveyed before or after undergoing clinician examination. Moreover, this preference
was consistent across all age groups, even the youngest age group (16–19 years) who are usually
presumed to preclude intimate examinations because of embarrassment or discomfort. The
conclusions from these two studies cannot be generalized as neither looked into the reason for
such preferences or sought opinion beyond clinic attendance. Nevertheless they highlight the
importance of educating patients about the limited evidence of the benefits of genital examina-
tion whilst stressing the effectiveness of self-sampling, in order to enable patients to make
informed choices.
This systematic review identifies a lack of standardization for self-sampling methods, and
the use of different analytic methods for STI detection and sampling procedures make it diffi-
cult to make any suggestion regarding what should be considered as the best self-sampling
practice. The settings of the studies ranged from specialist centres to non-healthcare settings,
with the majority of studies conducted in non-specialist healthcare settings. Some (n = 7) stud-
ies were conducted in sexual health clinics and these participants may be a subgroup of regular
clinic attendants who have been empowered, over years of experience, to take more initiative in
self-care and held different views compared to the normal population. However, as only a mi-
nority of the studies were conducted in such specialist settings, we believe that findings of this
review are generalizable to wider settings. The majority of studies used either self-completed or
interviewer-administered questionnaires to seek participant’s opinions regarding self-sam-
pling, but only a few (n = 5/45) provided the exact wording of their survey instrument. Hence,
it is not clear whether these questionnaires had elicited patients’ opinions as intended. Unfortu-
nately, there is no reliable standard to measure outcome of ‘opinion questionnaires’ such as
patient acceptability. Rigorous attempts should be made to ensure the validity of these ques-
tionnaires. Furthermore, in the case of interviewer-administered questionnaires, patients’ ideas
may be subject to the researchers’ interpretation. The use of self-administered questionnaires
with an open-ended option may be a preferable option. Some studies [30] [5] also gathered the
opinions of participants who refused to self-sample which has highlighted some important po-
tential negativities of self-sampling. This bias is further compounded by the fact that some
studies have surveyed/interviewed fewer participants than sampled [28]. Patients’ views in
these studies were only partially sought or acceptability only investigated as part of a larger
study. Patients who did not accept the self-sampling offer are likely to have different opinions
which were mainly undocumented.
One might anticipate that socio-demographic and cultural factors would influence accep-
tance of and preferences for self-sampling. It is therefore, disappointing that not all studies col-
lected comprehensive socio-demographic details. A certain degree of variability existed
between studies conducted in different cultural and racial groups. A high response rate, where
reported, was generally found in ‘Non-Western’ (i.e. Non-European/Non-North American)
studies. This figure is particularly high in the studies conducted in Asia [60] (94%) or South
America [3] (84%) compared to the African study (45%) [33]. Potential differences in opinion
between ethnic groups have also been investigated by focus groups, where actual self-sampling
did not take place. For example, Forrest et al. [65] reported the attitudes of women of Indian,
Pakistani, African-Caribbean and of white British origin residing in the UK and found that the
majority of women had strong intentions to use self-test for HPV. Another focus group study
by Howard et al [66] examined the barriers to self-sampling in six ethnic groups (Afghani,
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Somali, Arabic, Chinese, Hispanic, and Canadian) residing in Canada. In these studies, despite
participants generally appreciating the benefits of self-sampling, all expressed a certain degree
of reservation.
The strength of this systematic review lies in the assessment of the reporting of the studies
using STROBE checklist. However, this review is subject to a number of limitations. We did
not include the studies published in language other than English which may have introduced
bias in the findings of this review. Nevertheless, this review did include studies from countries
such as India, Thailand, and Brazil. In addition, cost-effectiveness of self-sampling was not ad-
dressed in this review. However, we noted that two studies looked at the cost per specimen re-
ceived [26,54], one study calculated a net profit of self-testing over clinic-testing [38], and two
studies looked at the cost that participants were willing to pay for self-sampling [3,33,67]. The
anticipated cost for the health services is important for STI self- sampling and future studies
need to conduct economic evaluations of self-sampling to develop an effective policy for the
management of STIs.
In conclusion, despite the heterogeneity among studies, particularly of screening methods,
populations studied, settings of self-sampling and methods of ascertaining acceptability, this
systematic review has demonstrated that self-sampling is a well-accepted and preferred ap-
proach to test for STIs. In the current context of low uptake of STI testing, using home/
community-based self-sampling method could be a promising approach to increase participa-
tion among hard-to-reach populations, and to reduce sampling related barriers such as stigma,
confidentiality and inconvenience. Although, acceptance or preference for self-sampling does
not necessarily reflect actual testing behaviour, this review suggests that self-sampling may be a
feasible option for those who are hesitant to undergo clinician sampling.
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